NewBiologix aims to revolutionize the production of viral vectors for gene and cell therapies with its cutting-edge bioinformatics platform and advanced R&D capabilities.

NewBiologix pioneers breakthrough gene therapies with USD 50 million investment

Tuesday 16 May 2023
The new financing round brings the total funds raised by Novostia to just over EUR 15 million euros. The company has also received public subsidies from the European Union and the canton of Vaud.

Novostia to launch first-in-human trials of its innovative artificial heart valve

Monday 8 May 2023
CSL Behring celebrates its arrival on campus with Biopôle's community. (from left to right: Nasri Nahas, Pierre-Jean Wipff and Adrian Zuercher)

CSL Behring expands R&D presence with new office at Biopôle

Monday 8 May 2023
The collaboration will combine RetinAI's Discovery platform and AI tools with Boehringer Ingelheim's research in retinal diseases.

RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment

Wednesday 26 April 2023
The Siegfried Group is a global life sciences company with facilities in Switzerland, Germany, Spain, France, Malta, the United States, and China.

Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz

Wednesday 26 April 2023
The Swiss Biotech Report 2023 recently unveiled an impressive portrait of Switzerland's thriving biotech sector.

Western Switzerland’s biotech sector flourishes amidst global challenges

Wednesday 26 April 2023
CTG is a medical device used during pregnancy and childbirth to monitor the baby’s heart rate and the mother’s contractions.

Revolutionizing prenatal care and monitoring using AI-based systems

Tuesday 25 April 2023
Medtech company Distalmotion has created Dexter, a surgical robot combining laparoscopy & robotics for minimally invasive care.

Distalmotion secures USD 150 million to revolutionize robotic surgery

Monday 24 April 2023
Focused on prioritizing patients during consultations, HealthMe delivers tailored, real-time outputs accessible to both patients and clinicians.

HealthMe Technologies thrives in Valais’ digital health ecosystem

Monday 3 April 2023
An EPFL start-up from the Laboratory of Systems Biology and Genetics, Alithea Genomics is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs.

Alithea Genomics secures CHF 500,000 to boost RNA sequencing technology

Monday 27 March 2023

This website uses cookies to improve user experience. More information